AAA October 2016 – Page 5

Mavalon comes out of Domain with $9.8m

France-based biopharmaceutical company Domain Therapeutics has launched a spinout called Mavalon Therapeutics to develop a Parkinson’s disease treatment, and venture capital firm Medicxi has pledged up to €9m ($9.8m) in funding. Mavalon is working to develop a small-molecule oral treatment for Parkinson’s that will work by inducing the production of Glial cell line-Derived Neurotrophic Factor, a… Continue reading Mavalon comes out of Domain with $9.8m

Corporate venturing deal net: 17-21 October 2016

Renegade Brands, USA, a US-based developer of a high-performance cleaning system for sporting apparel called Sweat X, completed a $5m funding round on Tuesday led by diversified holding group Eldridge Industries and backed by Elysian Park Ventures, the venture capital vehicle formed by the ownership group of the Los Angeles Dodgers baseball team. Renegade is… Continue reading Corporate venturing deal net: 17-21 October 2016